Theator appoints Kavi Vyas as Chief Commercial Officer

Surgical intelligence platform theator has announced that it has appointed Kavi Vyas as its Chief Commercial Officer. Vyas will join its senior leadership to increase the company’s global visibility and accelerate institutional adoption of its platform that can tackle variability and disparity in surgical care.

“I am excited to join theator on their mission to apply technological innovation toward improving best practices for surgeons all over the world,” said Kavi Vyas, CCO of theator. “Theator has done a tremendous job creating an extremely comprehensive, data-driven platform already adopted by some of the world’s leading medical institutions. I’m looking forward to building upon theator’s current success alongside this inspiring group of experts in the surgical and machine learning fields.”

Vyas has 15 years of experience in medtech and most recently served as VP Marketing at Viz.ai. Before that, he was at Penumbra, a healthcare company focused on technology. While there, he launched its Global Vascular and Neurovascular Embolization businesses.

“We are thrilled to welcome Kavi to theator. He comes with an exceptionally impressive skillset based on extensive experience of AI applications in healthcare, which will be instrumental toward theator’s growth,” added Dr. Tamir Wolf, CEO and Co-Founder of theator. “Kavi’s creativity, business-savvy, and record of success at leading medtech companies, and his commitment to using technology to solve issues in healthcare, will be a huge asset to our team as we further commit to our mission of using AI to reduce and eliminate inequalities in surgical care.”

Theator was founded in 2018 by Wolf and Dotan Asselmann, who serves as the company’s CTO. To date, the company has raised $18.5 million to help health systems gain deeper visibility across surgical departments and help surgeons pinpoint improve their performances. the company recently announced a new collaboration with Mayo Clinic’s urology and gynecology departments.